NAME,(Re),(Prot),ADDITIONAL COMMENTS,TYPE,INFORMATION,STATISTICS,RANGE,MISSINGS
,,,,,,,,
id,,,,numeric,study ID,avg = 231.500 +/- 133.512,[1.000 ; 462.000],0
,,,,,,,,
age,,,,numeric,Age at operation (years),avg = 72.091 +/- 7.018,[57.000 ; 93.000],0
,,,,,,,,
surviv,,,,numeric,Survival from operation date (months),avg = 41.481 +/- 34.065,[0.000 ; 116.000],0
,,,,,,,,
status,,,Only useful ?Alive/Death from colorectal cancer,nominal,Current status,"mode = Dead (293), least = Alive (169)","Alive (169), Dead (293)",0
,,,,,,,,
cause,,,,nominal,Cause of death,"mode = Death from colorectal cancer (228), least = Unknown (1)","Alive (169), Death from colorectal cancer (228), Death from unrelated cause (64), Unknown (1)",0
,,,,,,,,
sex,,,,nominal,Sex,"mode = Male (266), least = Female (196)","Male (266), Female (196)",0
,,,,,,,,
tumtype,,,"Based on analysis of biopsy images / Chemical analysis, Remove Unknown",nominal,Tumour histological type (histology ?study of microscopic anatomy of cells and tissue),"mode = Adenocarcinoma (392), least = Columnar adenocarcinoma (4)","Adenocarcinoma (392), Mucinous adenocarcinoma (51), Columnar adenocarcinoma (4), Signet ring mucinous adenocarcinoma (7), Unknown (8)",0
,,,,,,,,
diff,,,Three tier system of Anaplasia (lack of cell differentiation),ordinal,Tumour grade of differentiation,"mode = Moderate (353), least = Unknown (9)","Well (29), Moderate (353), Poor (71), Unknown (9)",0
,,,,,,,,
tsite,,,Different symptoms for different location. Different growth properties,nominal,Site of primary finding,"mode = Rectal (181), least = Unknown (43)","Right colon (142), Left colon (96), Rectal (181), Unknown (43)",0
,,,,,,,,
dukes,,,"Original Dukes Classification ?4 types, C has 2 subtypes",ordinal,Dukes stage,"mode = B (177), least = Unknown (3)","A (68), B (177), C1 (138), C2 (21), D (55), Unknown (3)",0
,,,,,,,,
Dukes4,,,"As above, but without C subtypes and unknowns into missing",ordinal,Dukes A-D,avg = 2.438 +/- 0.885,[1.000 ; 4.000] (1) A (2) B (3) C (4) D,3
,,,,,,,,
Duke2,X,,Low/High ?Generates 2 classes from the above 4,ordinal,Duke2,avg = 1.466 +/- 0.499,"[1.000 ; 2.000]  (1) Low = A + B, (2) High = C + D",3
,,,,,,,,
tstage,,,Tumor site description ?how it spread there,ordinal,T stage (UICC - International Union Against Cancer),"mode = 3 (273), least = carcinoma in situ (6)","1 (21), 2 (53), 3 (273), 4a (15), 4b (78), carcinoma in situ (earliest) (6), unknown (16)",0
,,,,,,,,
tstage2,X,,"As above but without 4a,4b and unknowns into missing",ordinal,T Stage 2,"mode = 3 (273), least = carcinoma in situ (6)","1 (21), 2 (53), 3 (273), 4 (93), carcinoma in situ (6)",16
,,,,,,,,
nstage,,,"Degree of spread to regional lymph nodes | no A,B,C subcategories",ordinal,Nodal status (UICC),"mode = 0 (242), least = unknown (27)","0 (242), 1 (109), 2 (84), unknown (27)",0
,,,,,,,,
mstage,,,"Degree of spread to distant organs | no A,B subcategories",ordinal,Distant mets (UICC),"mode = 0 (402), least = unknown (6)","0 No spread (402), 1 Spread (54), unknown (6)",0
,,,,,,,,
vasc,,,Cancer cells getting into venous system,ordinal,Extramural vascular invasion,"mode = No (224), least = Unknown (110)","No (224), Yes (128), Unknown (110)",0
,,,,,,,,
EMVI,X,,As above but unknowns turned into missing,nominal,VI (extramural),avg = 0.364 +/- 0.482,"[0.000 ; 1.000] (0) No, (1) Yes",110
,,,,,,,,
disspec,,,Died from complications of operation,nominal,Disease specific survival,avg = 0.494 +/- 0.500,"[0.000 ; 1.000] (0) No, (1) Yes (died from complications)",0
,,,,,,,,
DSS,,,,nominal,DSS,avg = 0.398 +/- 0.490,[0.000 ; 1.000],0
,,,,,,,,
newtnm,,,"5 TNM stages ?0, I, II, III, IV, Unknown",ordinal,TNM stage,avg = 2.452 +/- 0.955,"[0.000 ; 5.000] (0) 0, (1) I, (2) II, (3) III, (4) IV, (5) Unknown",0
,,,,,,,,
tnm4cat,X,,"As above, but combines 0 and I",ordinal,"TNM stage (0+1) = 1, 2, 3, 4 and unknown",avg = 2.459 +/- 0.942,"[1.000 ; 5.000] (1) 0 + I, (2) II, (3) III, (4) IV, (5) Unknown",0
,,,,,,,,
tnmlowvs,X,,"As newtnm, but creates High and Low (ERROR ?Includes Unknowns in High)",ordinal,TNM stage low vs high,avg = 1.468 +/- 0.499,"[1.000 ; 2.000] (1) Low = 0,I,II; (2) High = III,IV, Unknowns",0
,,,,,,,,
colorect,X,,As tsite but no separation of Left/Right colon,nominal,Site of primary,avg = 1.578 +/- 0.657,"[1.000 ; 3.000] (1) Colon, (2) Rectal, (3) Unknown",0
,,,,,,,,
Location,X,,As above but unknowns turned into missing,nominal,Site of primary exc. unknowns,avg = 1.432 +/- 0.496,"[1.000 ; 2.000] (1) Colon, (2) Rectal",43
,,,,,,,,
distmets2,X,,"Same as mstage, unknowns into missing",nominal,Distant Mets,avg = 1.118 +/- 0.323,[1.000 ; 2.000] (1) No spread (2) Spread,6
,,,,,,,,
cd46,,X,Some tumours express this protein,nominal,CD46,avg = 1.474 +/- 0.500,"[1.000 ; 2.000]  (1) Low, (2) High",13
,,,,,,,,
cd59a,,X,Antigen / Gene,nominal,CD59 staining,"mode = Negative (387), least = Positive (62)","Negative (387), Positive (62) ? is present",13
,,,,,,,,
hl,,X,"MHC Class I, seq. A protein",nominal,MICA recode High/low,avg = 1.463 +/- 0.499,"[1.000 ; 2.000] (1) Low, (2) High",13
,,,,,,,,
p53,,X,Tumour suppressor protein,nominal,p53,avg = 1.503 +/- 0.501,[1.000 ; 2.000] (1) Positive (2) Negative,17
,,,,,,,,
ki67,,X,Protein associated with cell proliferation,nominal,Ki-67,avg = 1.697 +/- 0.460,"[1.000 ; 2.000] (1) Low, (2) High",20
,,,,,,,,
bcl2,,X,B-Cell lymphoma 2,nominal,Bcl-2,avg = 1.455 +/- 0.499,"[1.000 ; 2.000] (1) Low, (2) High",25
,,,,,,,,
p53bcl2,X,,Combination of p53 and bcl2,nominal,p53 / Bcl-2 combined,avg = 2.340 +/- 1.104,"[1.000 ; 4.000] (1) [1,1]; (2) [2,1]; (3) [2,2]; (4) [1,2] ?Missing don't match",30
,,,,,,,,
chk2,,X,CHECK 2 ?checkpoint homolog 2,nominal,Chk-2,avg = 1.880 +/- 0.326,"[1.000 ; 2.000] (1) Negative, (2) Positive",22
,,,,,,,,
pchk2,,X,Phospho-CHK2 Antibody,nominal,phospho chk-2,avg = 1.333 +/- 0.472,"[1.000 ; 2.000] (1) Negative, (2) Positive",23
,,,,,,,,
chk1,,X,CHECK 1 ?Cell cycle control / Mitosis,nominal,Chk-1,avg = 1.249 +/- 0.433,"[1.000 ; 2.000] (1) Negative, (2) Positive",24
,,,,,,,,
pchk1,,X,Phospho-CHK1 Antibody,nominal,phospho chk-1,avg = 1.128 +/- 0.335,"[1.000 ; 2.000] (1) Negative, (2) Positive",26
,,,,,,,,
atm,,X,Ataxia Telangiectasia Mutated protein,nominal,ATM,avg = 1.549 +/- 0.498,"[1.000 ; 2.000] (1) Negative, (2) Positive",45
,,,,,,,,
b2m,,X,Component of MHC-1 Molecules,nominal,Beta-2 microglobulin,avg = 1.833 +/- 0.373,"[1.000 ; 2.000] (1) Negative, (2) Positive *",7
,,,,,,,,
hc10,,X,Heterochromatin,ordinal,HC-10,avg = 2.629 +/- 0.712,[1.000 ; 3.000] (1) Negative (2) Low (3) High *,7
,,,,,,,,
mhc,,X,Major Histocompatibility Complex Class I,ordinal,MHC class-I combined,avg = 2.448 +/- 0.853,[1.000 ; 3.000] (1) Negative (2) Low (3) High *,7
,,,,,,,,
mhcallele,,X,,nominal,mhcallele,avg = 1.073 +/- 0.260,"[1.000 ; 2.000] (1) Negative, (2) Positive *",7
,,,,,,,,
ITTCcat,,,Intra-tumour T-Cells,nominal,TCPAA (Binned) T-Cell Proliferation Array,"mode = 15.01+ (234), least = <= 15.00 (121)","<= 15.00 (121), 15.01+ (234)",107
,,,,,,,,
tcellmhc,X,,T-Cell + MHC (mhc + ITTCcat),nominal,tcellmhc,avg = 4.412 +/- 1.773,"[1.000 ; 6.000] (1) Mhc -ve T cell, (2) Mhc lo T cell, (3) Mhc hi T cell, (4) Mhc -ve T cell, (5) Mhc lo T cell, (6) Mhc hi T cell",108
,,,,,,,,
p27nuc,,X,Cyclic dependant kinase inhibitor 1B (nucleus),nominal,p27 nuclear,avg = 0.519 +/- 0.500,"[0.000 ; 1.000] (0) Negative, (1) Positive *",44
,,,,,,,,
p27cyto,,X,Cyclic dependant kinase inhibitor 1B (cytoplasm),nominal,p27 cytoplasmic,avg = 0.189 +/- 0.392,"[0.000 ; 1.000] (0) Negative, (1) Positive *",44
,,,,,,,,
betmembr,,X,Beta-catenine (membrane),nominal,beta-catenin membrane,avg = 0.914 +/- 0.281,"[0.000 ; 1.000] (0) Negative, (1) Positive *",34
,,,,,,,,
betcytop,,X,Beta-catenine (cytoplasm),nominal,beta-catenin cytoplasmic,avg = 0.671 +/- 0.471,"[0.000 ; 1.000] (0) Negative, (1) Positive *",34
,,,,,,,,
betnucle,,X,Beta-catenine (nucleus),nominal,beta-catenin nuclear,avg = 0.479 +/- 0.500,"[0.000 ; 1.000] (0) Negative, (1) Positive *",34
,,,,,,,,
p21,,X,Cyclic dependant kinase inhibitor 1,nominal,p21,avg = 0.421 +/- 0.494,"[0.000 ; 1.000] (0) Negative, (1) Positive *",101
,,,,,,,,
p2150,,X,Cyclic dependant kinase inhibitor 1,nominal,p21 >50 vs <50%,avg = 0.136 +/- 0.343,"[0.000 ; 1.000] (0) p21 > 50%, (1) p21 < 50% *",101
,,,,,,,,
statcyto.p,,X,Signal transducer and activator of transcriptions I,numeric,Stat1 cytoplasmic percentage,avg = 78.111 +/- 38.104,[0.000 ; 100.000],57
,,,,,,,,
statnuc.p,,X,Signal transducer and activator of transcriptions I,numeric,Stat1 nuclear percentage,avg = 11.568 +/- 28.379,[0.000 ; 100.000],57
,,,,,,,,
statcyto.int,,X,Signal transducer and activator of transcriptions I,ordinal,Stat1 cytoplasmic intensity,"mode = Weak (168), least = Strong (38)","No staining (60), Weak (168), Moderate (139), Strong (38)",57
,,,,,,,,
statnuc.int,,X,Signal transducer and activator of transcriptions I,ordinal,Stat1 nuclear intensity,"mode = No staining (332), least = Weak (8)","No staining (332), Weak (8), Moderate (41), Strong (23)",58
,,,,,,,,
statcyto2,,X,Signal transducer and activator of transcriptions I,nominal,Stat1 cytoplasmic post neg,avg = 0.852 +/- 0.356,"[0.000 ; 1.000] (0) Negative, (1) Positive",57
,,,,,,,,
int2,,X,Proto-oncogene protein (FGF-3) (cytoplasm),nominal,cytoint2,avg = 0.437 +/- 0.497,"[0.000 ; 1.000] (0) Low, (1) High",57
,,,,,,,,
nucint2,,X,Proto-oncogene protein (FGF-3) (nucleus),nominal,nucint2,avg = 0.158 +/- 0.366,"[0.000 ; 1.000] (0) Low, (1) High",58
,,,,,,,,
trailint,,X,TRAIL-R2 Killer / DR5 (intensity),ordinal,TRAILR2 Intensity,"mode = Moderate (175), least = No staining (21)","No staining (21), Weak (151), Moderate (175), Strong (54)",61
,,,,,,,,
trailper,,X,TRAIL-R2 Killer / DR5 (percentage),numeric,TRAILR2 %,avg = 99.802 +/- 1.789,[80.000 ; 100.000],83
,,,,,,,,
trailint2,,X,TRAIL-R2 Killer / DR5,nominal,TRAIL-R2 Intensity2,"mode = 2.0 (229), least = 1.0 (172)","2.0 High (229), 1.0 Low (172)",61
,,,,,,,,
blc2trailr2,X,,Mixture of bcl2 and TRAIL-R2,nominal,Bcl-2 vs TRAIL-R2,"mode = Bcl-2+ TRAIL-R2 Str (116), least = Bcl2+ TRAIL-R2 Weak (62)","Bcl-2+ TRAIL-R2 Str (116), Bcl2+ TRAIL-R2 Weak (62), Bcl2- TRAIL-R2 Str (107), Bcl2- TRAIL-R2 Weak (106)",71
,,,,,,,,
bcl2trailr2ii,X,,"As blc2trailr2 ?pos bcl2 | str,weak TRAIL-R2",nominal,Bcl-2 vs TRAIL-R2 ii,"mode = Bcl2 + TRAIL-R2 Str (116), least = Bcl2+ TRAIL-R2 Weak (62)","Bcl2 + TRAIL-R2 Str (116), Bcl2+ TRAIL-R2 Weak (62)",284
,,,,,,,,
bcl2trailr2iii,X,,"As blc2trailr2 ?pos/neg bcl2 | str,str TRAIL-R2",nominal,Bcl-2 vs TRAIL-R2 iii,"mode = Bcl2+ TRAIL-R2 Str (116), least = Bcl2- TRAIL-R2 Str (107)","Bcl2+ TRAIL-R2 Str (116), Bcl2- TRAIL-R2 Str (107)",239
,,,,,,,,
p53trailr2,X,,Mixture of p53 and TRAIL-R2,nominal,p53 and TRAIL-R2 combined,"mode = p53+ TRAIL-R2 Str (114), least = p53- TRAIL-R2 Weak (82)","p53+ TRAIL-R2 Str (114), p53+ TRAIL-R2 Weak (86), p53- TRAIL-R2 Str (109), p53- TRAIL-R2 Weak (82)",71
,,,,,,,,
p53trailr2ii,X,,"As p53trailr2 ?pos/neg p53 | weak,str TRAIL-R2",nominal,p53 and TRAIL-R2 combined ii,"mode = p53- TRAIL-R2 Str (109), least = p53+ TRAIL-R2 Weak (86)","p53+ TRAIL-R2 Weak (86), p53- TRAIL-R2 Str (109)",267
,,,,,,,,
bcl2trailr2iv,X,,"As bcl2trailr2ii ?pos bcl2 (bcl2,not-bcl2) | pos TRAIL-R2",nominal,Bcl-2+/TRAIL-R2+ vs rest,"mode = Not Bcl2+/TRAIL-R2+ (275), least = Bcl-2+/TRAIL-R2+ (116)","Bcl-2+/TRAIL-R2+ (116), Not Bcl2+/TRAIL-R2+ (275)",71
,,,,,,,,
p53trailr2iii,X,,"As p53trailr2 ?neg p53 (p53,not-p53) | pos TRAIL-R2",nominal,p53-ve/TRAIL-R2+ve vs others,"mode = Not p53-ve/TRAIL-R2+ve (282), least = p53-ve/TRAIL-R2+ve (109)","p53-ve/TRAIL-R2+ve (109), Not p53-ve/TRAIL-R2+ve (282)",71
,,,,,,,,
p53trailr2iv,X,,"As p53trailr2 ?pos p53 (p53,not-p53) | neg TRAIL-R2",nominal,p53+ve/TRAIL-R2-ve vs others,"mode = Not p53+ve/TRAIL-R2-ve (305), least = p53+ve/TRAIL-R2-ve (86)","p53+ve/TRAIL-R2-ve (86), Not p53+ve/TRAIL-R2-ve (305)",71
,,,,,,,,
MLH1nuc,,X,,nominal,MLH1 nuclear intensity,avg = 1.435 +/- 1.011,"[0.000 ; 3.000] (0) Negative, (1) Weak, (2) Moderate, (3) Strong",46
,,,,,,,,
MSH2nuc,,X,,nominal,MSH2 nuclear intensity,avg = 1.928 +/- 0.934,"[0.000 ; 3.000] (0) Negative, (1) Weak, (2) Moderate, (3) Strong",44
,,,,,,,,
mlhnucre,X,,,nominal,MLH1 nuclear weak and strong,avg = 0.476 +/- 0.500,"[0.000 ; 1.000] (0) Weak, (1) Strong",46
,,,,,,,,
MLH1stained,X,,,nominal,MLH1 positive and negative,avg = 0.786 +/- 0.411,"[0.000 ; 1.000] (0) Positive, (1) Negative",46
,,,,,,,,
MSH2nucre,X,,,nominal,MSH2 nuclear positve and negative,avg = 0.737 +/- 0.441,"[0.000 ; 1.000] (0) Positive, (1) Negative",44
,,,,,,,,
MLH1MSH2,X,,,nominal,COMBINED +/- MLH1 AND MSH2,avg = 2.320 +/- 1.109,[0.000 ; 3.000],52
,,,,,,,,
MSIP,,,,nominal,MSIP+/DEFECTIVE,avg = 0.854 +/- 0.354,[0.000 ; 1.000],52
,,,,,,,,
msi,X,,,nominal,Micro-satellite instability,avg = 0.752 +/- 0.432,"[0.000 ; 1.000] (0) Missing MLH1, MSH2 or both, (1) MLH1 and MSH2 positive",46
,,,,,,,,
MMRnegative,X,,,nominal,MSH2 and/or MLH1 NEG,avg = 2.034 +/- 1.403,[0.000 ; 3.000],52
,,,,,,,,
combined,X,,,nominal,combination of MLH1nuc(+/-) and STAT1 nuc (combined+/-),avg = 1.776 +/- 0.899,[0.000 ; 3.000],60
,,,,,,,,
Chemo,,,,nominal,Chemotherapy,avg = 0.212 +/- 0.634,"[0.000 ; 3.000] (0) No chemotherapy, (1) 5FU Chemo, (2) Others adjuvant, (3) Chemo for mets/recurr",0
,,,,,,,,
Radio,,,,nominal,radiotherapy,avg = 0.416 +/- 1.246,"[0.000 ; 6.000](0) no radiotherapy, (1) pre operative long course, (2) pre operative short course, (3) post operative radiotherapy, (4) both pre and post, (5) unspecified adjuvant, (6) rt for mets or recurr",0
,,,,,,,,
radiorec,,,,nominal,radiorec,avg = 0.096 +/- 0.295,"[0.000 ; 1.000] (0) no RT, (1) RT",13
,,,,,,,,
CHEMOREC,,,,nominal,CHEMOREC,avg = 0.099 +/- 0.299,"[0.000 ; 1.000] (0) no CT, (1) CT",17
,,,,,,,,
FLIPL,,X,,nominal,FLIPL,avg = 1.338 +/- 0.653,[0.000 ; 3.000],66
,,,,,,,,
FLIPREC,X,,,nominal,FLIPREC,avg = 0.343 +/- 0.475,[0.000 ; 1.000],66
,,,,,,,,
fliprec2,,X,,nominal,fliprec2,avg = 1.048 +/- 0.214,[1.000 ; 2.000],66
,,,,,,,,
DR4,,X,,nominal,DR4,avg = 1.868 +/- 1.201,"[0.000 ; 4.000] (0) Negative, (1) Weak, (2) Moderate, (3) Strong, (4) Missing",0
,,,,,,,,
DR4rec,,X,,nominal,DR4rec,avg = 0.454 +/- 0.499,[0.000 ; 1.000],68
,,,,,,,,
DR4pos,,,,nominal,DR4pos,avg = 0.893 +/- 0.309,[0.000 ; 1.000],68
,,,,,,,,
trailr2rec,,,,nominal,trailr2rec,avg = 0.571 +/- 0.496,[0.000 ; 1.000],61
,,,,,,,,
pAKTcyto,,X,,nominal,phospho-AKT - cytoplasmic,avg = 1.053 +/- 0.756,[0.000 ; 2.000],85
,,,,,,,,
pAKTnuc,,X,,nominal,phospho-AKT - nuclear,avg = 1.305 +/- 0.978,[0.000 ; 3.000],85
,,,,,,,,
pAKTnucrec,X,,,nominal,pAKT Nuclear recoded (+ vs -),avg = 0.759 +/- 0.428,[0.000 ; 1.000],85
,,,,,,,,
pAKTcytorec,X,,,nominal,pAKT cytoplasmic recoded as - vs +,avg = 0.740 +/- 0.439,[0.000 ; 1.000],85
,,,,,,,,
pAKTtotal,,X,,nominal,pAKTtotal,avg = 2.257 +/- 0.987,[0.000 ; 3.000],85
,,,,,,,,
CD24,,X,,nominal,CD24 ordinal,avg = 1.875 +/- 0.961,[0.000 ; 3.000],117
,,,,,,,,
CD24ordrec,X,,,nominal,"CD24 ordinal, recoded into low vs. high",avg = 0.655 +/- 0.476,[0.000 ; 1.000],117
,,,,,,,,
CD24Hscore,,,,numeric,CD24 H Score,avg = 159.557 +/- 91.492,[0.000 ; 300.000],117
,,,,,,,,
CD24lum,,X,,nominal,CD24 luminal,avg = 0.388 +/- 0.488,[0.000 ; 1.000],117
,,,,,,,,
NucCD24,,X,,nominal,CD24 nuclear,avg = 0.133 +/- 0.340,[0.000 ; 1.000],117
,,,,,,,,
ATR,,X,,nominal,ATR,avg = 1.830 +/- 0.784,[0.000 ; 3.000],85
,,,,,,,,
ATRRECOD,X,,,nominal,ATR as + or -,avg = 0.695 +/- 0.461,[0.000 ; 1.000],85
,,,,,,,,
CD24Hrec,,,,nominal,CD24 H Score (Binned),"mode = Intermediate (132), least = Negative (30)","Negative (30), Low (87), Intermediate (132), High (96)",117
,,,,,,,,
pS6,,,,numeric,p-S6 H-score,avg = 55.080 +/- 67.147,[0.000 ; 300.000],85
,,,,,,,,
pS6rec,,,,nominal,pS6 recoded hi vs low (around median of 30),avg = 0.504 +/- 0.501,[0.000 ; 1.000],85
,,,,,,,,
pS6negpos,,X,,nominal,pS6 (Negative v Positive),avg = 0.621 +/- 0.486,[0.000 ; 1.000],85
,,,,,,,,
PI9,,X,,nominal,PI-9,avg = 1.402 +/- 0.733,[0.000 ; 3.000],96
,,,,,,,,
FLIPsCyto,,X,,nominal,FLIP-short (cytoplasmic),avg = 1.982 +/- 0.725,[1.000 ; 3.000],83
,,,,,,,,
FLIPsNuc,,X,,nominal,FLIP-short (Nuclear),avg = 0.063 +/- 0.243,[0.000 ; 1.000],80
,,,,,,,,
FLIP,,X,,nominal,FLIP (Long or Short),avg = 0.248 +/- 0.433,[0.000 ; 1.000],35
,,,,,,,,
pERK,,X,,nominal,p-ERK 4 categories,avg = 0.253 +/- 0.560,[0.000 ; 3.000],122
,,,,,,,,
pERKrec,,,,nominal,p-ERK (Negative v Positive),avg = 0.200 +/- 0.401,[0.000 ; 1.000],122
,,,,,,,,
IRF2,,X,,nominal,IRF-2 in 4 categories,avg = 2.021 +/- 0.792,[0.000 ; 3.000],174
,,,,,,,,
IRF1,,,,nominal,IRF-1 (scored by Ahmad),avg = 0.518 +/- 0.500,[0.000 ; 1.000],72
,,,,,,,,
Tcells,,,,numeric,Tcells,avg = 45.980 +/- 34.528,[1.000 ; 100.000],363
,,,,,,,,
CoreArea,,,,numeric,Core area in mm square,avg = 0.310 +/- 0.073,[0.064 ; 0.680],106
,,,,,,,,
CellsPerArea,,,,numeric,CellsPerArea,avg = 153.828 +/- 109.312,[2.786 ; 404.494],363
,,,,,,,,
Tcellsintumor,,,,numeric,T cells within tumor nests,avg = 8.986 +/- 14.496,[0.000 ; 110.000],107
,,,,,,,,
TperArea,,,,numeric,TperArea,avg = 29.632 +/- 46.435,[0.000 ; 392.857],107
,,,,,,,,
JJ,,,,nominal,T cells within tumor nests (Binned),"mode = <= 2 (142), least = 3 - 7 (104)","<= 2 (142), 3 - 7 (104), 8+ (109)",107
,,,,,,,,
at20,,,,nominal,at20,avg = 0.383 +/- 0.487,[0.000 ; 1.000],107
,,,,,,,,
at25,,,,nominal,TperArea (Binned),"mode = <=25 (246), least = >25 (109)","<=25 (246), >25 (109)",107
,,,,,,,,
at30,,,,nominal,at30,avg = 0.259 +/- 0.439,[0.000 ; 1.000],107
,,,,,,,,
at40,,,,nominal,at40,avg = 0.214 +/- 0.411,[0.000 ; 1.000],107
,,,,,,,,
at50,,,,nominal,at50,avg = 0.175 +/- 0.380,[0.000 ; 1.000],107
,,,,,,,,
nucint3,,,,nominal,STAT1nuclear3,avg = 0.374 +/- 0.883,[0.000 ; 3.000],58
,,,,,,,,
ITTC50stat13,,,,nominal,ITTC50stat13,avg = 0.021 +/- 0.143,[0.000 ; 1.000],128
,,,,,,,,
Perarea,,,,nominal,Percentage tumour area per core,avg = 2.552 +/- 0.929,[1.000 ; 4.000],107
,,,,,,,,
areaper,,,,nominal,areaper,avg = 2.448 +/- 0.929,[1.000 ; 4.000],107
,,,,,,,,
actualarea,,,,numeric,Actual Area,avg = 0.150 +/- 0.081,[0.030 ; 0.416],107
,,,,,,,,
TCPAA,,,,numeric,TCPAA,avg = 66.374 +/- 106.952,[0.000 ; 807.692],107
,,,,,,,,
TCPAAnegvspos,,,,nominal,TCPAAnegvspos,avg = 0.848 +/- 0.360,[0.000 ; 1.000],107
,,,,,,,,
CD16,,,,nominal,CD16,avg = 0.392 +/- 0.489,[0.000 ; 1.000],44
,,,,,,,,
CD3MHC,,,,nominal,CD3MHC,avg = 3.302 +/- 1.583,[0.000 ; 5.000],108
,,,,,,,,
Tstroma,,,,nominal,Peri-tumoural CD3+ cells,avg = 1.713 +/- 0.652,[1.000 ; 3.000],106
,,,,,,,,
CD68,,,,numeric,CD68,avg = 9.184 +/- 11.942,[0.000 ; 54.000],54
,,,,,,,,
CD68groups,,,,nominal,CD68 (Binned),"mode = <= 2 (159), least = 3 - 9 (119)","<= 2 (159), 3 - 9 (119), 10+ (130)",54
,,,,,,,,
CD68in2gps,,,,nominal,CD68 (Binned),"mode = <= 10 (292), least = 11+ (116)","<= 10 (292), 11+ (116)",54
,,,,,,,,
MHC2,,,,nominal,MHC-II in tumour,avg = 0.087 +/- 0.351,[0.000 ; 2.000],49
,,,,,,,,
MHC2cat,,,,nominal,MHC2cat,avg = 0.065 +/- 0.247,[0.000 ; 1.000],49
,,,,,,,,
apcMHC2,,,,nominal,MHC-II in stromal cells,avg = 0.930 +/- 1.030,[0.000 ; 3.000],47
,,,,,,,,
apcMHC2rec,,,,nominal,apcMHC2rec,avg = 0.487 +/- 0.500,[0.000 ; 1.000],47
,,,,,,,,
raetigbrown,,,,numeric,raetigbrown,avg = 92231.504 +/- 48372.490,[10.000 ; 236706.000],43
,,,,,,,,
raetigblue,,,,numeric,raetigblue,avg = 5077.709 +/- 5081.482,[0.000 ; 33924.000],43
,,,,,,,,
raetigrec,,,,nominal,raetigrec,avg = 1.229 +/- 0.421,[1.000 ; 2.000],43
,,,,,,,,
raetiebrown,,,,numeric,raetiebrown,avg = 136166.122 +/- 43553.295,[3824.000 ; 268224.000],45
,,,,,,,,
raetieblue,,,,numeric,raetieblue,avg = 25630.703 +/- 12690.440,[3490.000 ; 101115.000],45
,,,,,,,,
raetierec,,,,nominal,raetierec,avg = 1.487 +/- 0.500,[1.000 ; 2.000],45
,,,,,,,,
raetierec2,,,,nominal,raetierec2,avg = 1.787 +/- 0.410,[1.000 ; 2.000],45
,,,,,,,,
micabrown,,,,numeric,micabrown,avg = 154130.923 +/- 39119.185,[34337.000 ; 262103.000],61
,,,,,,,,
micablue,,,,numeric,micablue,avg = 27909.800 +/- 11178.227,[5437.000 ; 70173.000],61
,,,,,,,,
micarec,,,,nominal,micarec,avg = 1.514 +/- 0.500,[1.000 ; 2.000],61
,,,,,,,,
mica2,,,,nominal,mica2,avg = 1.703 +/- 0.457,[1.000 ; 2.000],61
,,,,,,,,
RAETigmica,,,,nominal,RAETigmica,avg = 1.175 +/- 1.061,[0.000 ; 3.000],84
,,,,,,,,
raetigmica3,,,,nominal,raetigmica3,avg = 1.161 +/- 1.057,[0.000 ; 3.000],84
,,,,,,,,
raetiemica,,,,nominal,raetiemica,avg = 2.347 +/- 1.022,[0.000 ; 3.000],82
,,,,,,,,
emica,,,,nominal,emica,avg = 2.179 +/- 1.141,[0.000 ; 3.000],82
,,,,,,,,
IGIE,,,,nominal,IGIE,avg = 1.257 +/- 1.007,[0.000 ; 3.000],65
,,,,,,,,
IGIErec,,,,nominal,IGIErec,avg = 1.239 +/- 1.003,[0.000 ; 3.000],65
,,,,,,,,
IGIErec2,,,,nominal,IGIErec2,avg = 1.433 +/- 0.825,[1.000 ; 3.000],65
,,,,,,,,
stresmols,,,,nominal,stresmols,avg = 4.716 +/- 2.166,[1.000 ; 8.000],99
,,,,,,,,
statmica,,,,nominal,statmica,avg = 1.624 +/- 0.997,[0.000 ; 3.000],95
,,,,,,,,
ulbp1browm,,,,numeric,ulbp1browm,avg = 46354.930 +/- 39170.150,[739.000 ; 199254.000],46
,,,,,,,,
ulbp1rec,,,,nominal,ulbp1rec,avg = 0.596 +/- 0.491,[0.000 ; 1.000],46
,,,,,,,,
ulbp2brown,,,,numeric,ulbp2brown,avg = 18056.579 +/- 22535.739,[47.000 ; 208945.000],34
,,,,,,,,
ulbp2rec,,,,nominal,ulbp2rec,avg = 0.523 +/- 0.500,[0.000 ; 1.000],34
,,,,,,,,
ulbp3brown,,,,numeric,ulbp3brown,avg = 25283.706 +/- 23806.452,[126.000 ; 142811.000],20
,,,,,,,,
ulbp3rec,,,,nominal,ulbp3rec,avg = 0.367 +/- 0.483,[0.000 ; 1.000],34
,,,,,,,,
ulbp12,,,,nominal,ulbp12,avg = 1.130 +/- 0.726,[0.000 ; 2.000],55
,,,,,,,,
ulbp13,,,,nominal,ulbp13,avg = 0.980 +/- 0.817,[0.000 ; 2.000],54
,,,,,,,,
ulbp23,,,,nominal,ulbp23,avg = 0.891 +/- 0.761,[0.000 ; 2.000],41
,,,,,,,,
micaulbp1,,,,nominal,micaulbp1,avg = 1.318 +/- 0.760,[0.000 ; 2.000],78
,,,,,,,,
micaulbp2,,,,nominal,micaulbp2,avg = 1.234 +/- 0.661,[0.000 ; 2.000],73
,,,,,,,,
micaulbp3,,,,nominal,micaulbp3,avg = 1.085 +/- 0.717,[0.000 ; 2.000],72
,,,,,,,,
igulbp1,,,,nominal,igulbp1,avg = 0.830 +/- 0.727,[0.000 ; 2.000],74
,,,,,,,,
igulbp2,,,,nominal,igulbp2,avg = 0.753 +/- 0.674,[0.000 ; 2.000],57
,,,,,,,,
igulbp3,,,,nominal,igulbp3,avg = 0.597 +/- 0.728,[0.000 ; 2.000],60
,,,,,,,,
ieulbp1,,,,nominal,ieulbp1,avg = 1.398 +/- 0.633,[0.000 ; 2.000],73
,,,,,,,,
ieulbp2,,,,nominal,ieulbp2,avg = 1.312 +/- 0.607,[0.000 ; 2.000],58
,,,,,,,,
ieulbp3,,,,nominal,ieulbp3,avg = 1.173 +/- 0.640,[0.000 ; 2.000],63
,,,,,,,,
micaittc,,,,nominal,micaittc,avg = 2.103 +/- 1.063,[0.000 ; 3.000],143
,,,,,,,,
caspase3,,,,nominal,caspase3,avg = 0.638 +/- 0.846,[0.000 ; 3.000],64
,,,,,,,,
caspase3per,,,,numeric,caspase3per,avg = 36.636 +/- 42.180,[0.000 ; 100.000],68
,,,,,,,,
caspase3nuc,,,,nominal,caspase3nuc,avg = 0.107 +/- 0.309,[0.000 ; 1.000],69
,,,,,,,,
caspase3percentlovhi,,,,nominal,caspase3percentlovhi,avg = 0.350 +/- 0.478,[0.000 ; 1.000],68
,,,,,,,,
cas3weakvstrong,,,,nominal,cas3weakvstrong,avg = 0.141 +/- 0.348,[0.000 ; 1.000],64
,,,,,,,,
cas3negvpos,,,,nominal,cas3negvpos,avg = 0.447 +/- 0.498,[0.000 ; 1.000],64
,,,,,,,,
cas3p53,,,,nominal,cas3p53,avg = 1.381 +/- 1.124,[0.000 ; 3.000],79
,,,,,,,,
Vegfa,,,,nominal,Vegfa,avg = 1.517 +/- 1.039,[0.000 ; 3.000],133
,,,,,,,,
stat1nuc2,,,,nominal,stat1 nuclear pos v neg,avg = 0.180 +/- 0.385,[0.000 ; 1.000],57
,,,,,,,,
socs1,,,,nominal,socs1,avg = 0.730 +/- 0.869,[0.000 ; 3.000],66
,,,,,,,,
nstat1socs1,,,,nominal,nstat1socs1,avg = 1.215 +/- 1.102,[0.000 ; 3.000],109
,,,,,,,,
vegfc,,,,nominal,vegfc,avg = 1.289 +/- 0.947,[0.000 ; 3.000],53
,,,,,,,,
PI9rec,,,,nominal,PI9rec,avg = 0.913 +/- 0.283,[0.000 ; 1.000],96
,,,,,,,,
itcc,,,,nominal,itcc,avg = 1.659 +/- 0.475,[1.000 ; 2.000],107
,,,,,,,,
p19itcc,,,,nominal,p19itcc,avg = 3.517 +/- 0.712,[1.000 ; 4.000],118
,,,,,,,,
vegfchilo,,,,nominal,vegfchilo,avg = 1.350 +/- 0.477,[1.000 ; 2.000],53
,,,,,,,,
vegfcittcc,,,,nominal,vegfcittcc,avg = 2.685 +/- 1.073,[1.000 ; 4.000],119
,,,,,,,,
SOCS1hilo,,,,nominal,SOCS1hilo,avg = 0.521 +/- 0.500,[0.000 ; 1.000],109
,,,,,,,,
IL17tc,,,,nominal,IL17tc,avg = 0.412 +/- 0.614,[0.000 ; 3.000],74
,,,,,,,,
IL17m,,,,nominal,IL17m,avg = 0.751 +/- 0.819,[0.000 ; 3.000],60
,,,,,,,,
ctenc,,,,numeric,h score cytoplasmic,avg = 116.466 +/- 57.684,[0.000 ; 250.000],104
,,,,,,,,
ctenn,,,,numeric,hscore nuclear,avg = 48.243 +/- 30.373,[10.000 ; 100.000],425
,,,,,,,,
ctencwml,,,,nominal,"weak<70,mod 70-120, hi >120",avg = 2.134 +/- 0.869,[0.000 ; 3.000],104
,,,,,,,,
crenn,,,,nominal,0 neagtive 1 positive,avg = 0.103 +/- 0.305,[0.000 ; 1.000],104
,,,,,,,,
cxcl12,,,,nominal,cxcl12,avg = 1.729 +/- 0.884,[0.000 ; 3.000],170
,,,,,,,,
cxcl12goodbad,,,,nominal,cxcl12goodbad,avg = 1.709 +/- 0.455,[1.000 ; 2.000],170
,,,,,,,,
CD8Tcells,,,,numeric,Cells/mm2,avg = 52.194 +/- 144.247,[0.000 ; 2091.255],109
,,,,,,,,
GradedCD8,,,,nominal,GradedCD8,avg = 0.801 +/- 0.641,[0.000 ; 2.000],110
,,,,,,,,
LovsHiCD8Tcells,,,,nominal,LovsHiCD8Tcells,avg = 0.125 +/- 0.331,[0.000 ; 1.000],110
,,,,,,,,
"The columns to use for predicting survival start from cd46 onwards ignoring Chemo, Radio, radiorec and CHEMOREC (plus you can use age and gender).  ",,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,* Inferred from other attributes,
